Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics
Go back to Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 160.14 +1.85 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $158.29 | 52 Week High | $58.46 | |||
| Open | $161.17 | 52 Week Low | $31.25 | |||
| Day High | $161.39 | P/E | N/A | |||
| Day Low | $159.32 | EPS | $-0.69 | |||
| Volume | 469,077 | |||||
